Bono Weighs in on Trump-Bruce Springsteen Drama: 'There's Only One Boss in America'
Bono is weighing in on the Bruce Springsteen and Donald Trump drama, as well as responding to the president's call for a 'major investigation' into Bono's support for Kamala Harris.
The U2 frontman recently appeared on Jimmy Kimmel Live!, where the host asked him, 'Whose side are you on, Trump or Bruce Springsteen?'
More from The Hollywood Reporter
Sean "Diddy" Combs' Assistant of 8 Years Accuses Him of Multiple Sexual Assaults During Testimony
Sean "Diddy" Combs' Ex-Assistant Testifies He Sexually Assaulted Her and Used Violence to Get His Way
John Fogerty Is Releasing "John's Versions" of Creedence Clearwater Revival Classics
After letting out a laugh, Bono responded, 'I think there's only one Boss in America,' referring to Springsteen's nickname, evoking loud applause from the audience.
The Trump-Springsteen drama started when the rock star slammed the Trump administration during a concert in the U.K., telling the audience that the U.S. is 'currently in the hands of a corrupt, incompetent and treasonous administration.' While the president vaguely threatened him in response, Springsteen has since doubled down on his claims at another concert.
Jimmy Kimmel later brought up Trump's rant that he posted on his social media platform Truth Social earlier this month, calling for an investigation into major recording acts and entertainment notables — including Bono, Springsteen, Beyoncé and Oprah Winfrey — who showed their support for Harris during her presidential campaign.
'I don't want to cut in on your action because I know the president at 1 a.m., or 1:30, or whatever that was, is usually thinking about you,' Bono quipped, referencing Kimmel and Trump's years-long feud.
'But two points I'll make,' the Grammy-winning musician continued. 'One, to be the company of Bruce Springsteen, Beyoncé, and Oprah — I'll play tambourine in that band. And two, U2 and I have never paid or played a show to support any candidate from any party. It has never happened.'
He later joked that Trump's Truth Social platform 'seems to be pretty antisocial' and is 'not very true a lot of the time.'
Bono also offered Kimmel his thoughts on why he thinks he was among the artists Trump has targeted. He said it 'might be the fact that I co-founded the One Campaign, which is, by design, bipartisan.' According to its website, the nonprofit advocates for economic and health opportunities in Africa.
'We've got a lot of very religious Catholics, Evangelicals, Conservatives who are very, very, very angry with the person that they voted into office having demolished instruments of mercy and compassion like USAID [United States Agency for International Development] or PEPFAR [United States President's Emergency Plan for AIDS Relief], which can save 26 million lives of people who have AIDS around the world,' the 'With Or Without You' singer added. 'That's the America that we love. That's the America that we all want to be part of. And they are not happy, and there will be trouble.'
Best of The Hollywood Reporter
Most Anticipated Concert Tours of 2025: Beyoncé, Billie Eilish, Kendrick Lamar & SZA, Sabrina Carpenter and More
Hollywood's Most Notable Deaths of 2025
Hollywood's Highest-Profile Harris Endorsements: Taylor Swift, George Clooney, Bruce Springsteen and More
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
30 minutes ago
- Fox News
WATCH LIVE: New Jersey gubernatorial candidate Jack Ciattarelli holds rally
All times eastern FOX News Radio Live Channel Coverage WATCH LIVE: New Jersey gubernatorial candidate Jack Ciattarelli holds rally
Associated Press
32 minutes ago
- Associated Press
The Knicks' all-in moves didn't get them all the way there. But they are getting close
NEW YORK (AP) — The New York Knicks went further than they'd gone in 25 years, just not as far as they hoped. They signaled they were serious about making a run at the NBA title when they traded for Mikal Bridges in the summer and then Karl-Anthony Towns in a preseason blockbuster, adding a top perimeter defender and an All-Star center to a lineup headlined by Jalen Brunson. Their all-in moves just couldn't get them all the way there. The Knicks were eliminated by the Indiana Pacers on Saturday, leaving them without a championship since 1973. But after advancing to the Eastern Conference finals for the first time since 2000 following consecutive second-round exits, they could at least feel that they are getting closer. 'So it's improvement from last year, but it's ultimately not what our ultimate goal is,' coach Tom Thibodeau said. After Boston rolled to the 2024 title and brought back all its key players, the Celtics were viewed as strong favorites in the East. Yet after building gradually since Leon Rose's arrival as team president in 2020, the Knicks weren't conceding anything to the champions. They re-signed OG Anunoby to the largest contract in team history, then traded five first-round picks in the deal to acquire Bridges from Brooklyn. Just as they were set to begin training camp, the Knicks dealt two starters in All-Star Julius Randle and Donte DiVincenzo, who had just set their single-season 3-point record, to get Towns from Minnesota. The moves made the Knicks good enough to get past the Celtics in the second round. But it turned out to not be the right roster against the deep and speedy Pacers, who knocked them out for the second straight season. 'You make the moves to win, so it hurts to not be able to bring an opportunity to the city for a championship,' Towns said. 'We've got a bunch of great guys in that locker room and the plan now is just to put ourselves in this position again and succeed next time.' First, Rose and the front office will have to evaluate just how close the Knicks really are. Their 51-31 record left them a distant third in the East behind Cleveland and Boston, and they went a combined 0-8 against those teams in the regular season before they finished off the Celtics in the second round after Jayson Tatum ruptured his Achilles tendon in Game 4. With two All-NBA selections in Brunson and Towns, the starting lineup is one of the NBA's strongest. The bench could use a boost, as the Knicks lack the solid depth of the Cavaliers and Celtics — and certainly of the Pacers. Still, after being mostly miles away for two decades, the Knicks have turned themselves into a contender. They have won 50 games in back-to-back seasons and made the playoffs in four of five under Thibodeau. Even after Saturday's defeat, there was belief that the Knicks will get another shot soon. 'The most confidence. Overconfident,' Brunson said when asked if he was confident the Knicks had a group that could win. 'Seriously. There's not an ounce of any type of doubt that I'm not confident with this group.' The extension their captain agreed to last summer that was far below maximum value could help add to it. And perhaps the Knicks are finally at the point that there isn't much to do. The Knicks surely will regret letting this chance get away, unable to recover from their Game 1 collapse at home when they blew a 14-point lead in the final 2:45 of the fourth quarter. So naturally, there was disappointment. That's all there had been in New York in the 2000s. Now there's also hope. 'And so I think the challenge for us is to look at it for what it is,' Thibodeau said. 'And it's, we finished in the top three, but we're falling short of the ultimate goal, and so for us it's to use that for motivation and determination to work all summer to prepare ourselves to make the final step and keep improving so we can achieve our goal.' ___ AP NBA:
Yahoo
35 minutes ago
- Yahoo
Do Merit Medical Systems' (NASDAQ:MMSI) Earnings Warrant Your Attention?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. Sometimes these stories can cloud the minds of investors, leading them to invest with their emotions rather than on the merit of good company fundamentals. Loss making companies can act like a sponge for capital - so investors should be cautious that they're not throwing good money after bad. Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Merit Medical Systems (NASDAQ:MMSI). While profit isn't the sole metric that should be considered when investing, it's worth recognising businesses that can consistently produce it. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. If a company can keep growing earnings per share (EPS) long enough, its share price should eventually follow. So it makes sense that experienced investors pay close attention to company EPS when undertaking investment research. It certainly is nice to see that Merit Medical Systems has managed to grow EPS by 34% per year over three years. As a general rule, we'd say that if a company can keep up that sort of growth, shareholders will be beaming. Careful consideration of revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. Merit Medical Systems maintained stable EBIT margins over the last year, all while growing revenue 8.2% to US$1.4b. That's a real positive. In the chart below, you can see how the company has grown earnings and revenue, over time. Click on the chart to see the exact numbers. View our latest analysis for Merit Medical Systems The trick, as an investor, is to find companies that are going to perform well in the future, not just in the past. While crystal balls don't exist, you can check our visualization of consensus analyst forecasts for Merit Medical Systems' future EPS 100% free. We would not expect to see insiders owning a large percentage of a US$5.6b company like Merit Medical Systems. But we do take comfort from the fact that they are investors in the company. Notably, they have an enviable stake in the company, worth US$132m. Holders should find this level of insider commitment quite encouraging, since it would ensure that the leaders of the company would also experience their success, or failure, with the stock. If you believe that share price follows earnings per share you should definitely be delving further into Merit Medical Systems' strong EPS growth. With EPS growth rates like that, it's hardly surprising to see company higher-ups place confidence in the company through continuing to hold a significant investment. On the balance of its merits, solid EPS growth and company insiders who are aligned with the shareholders would indicate a business that is worthy of further research. However, before you get too excited we've discovered 1 warning sign for Merit Medical Systems that you should be aware of. There's always the possibility of doing well buying stocks that are not growing earnings and do not have insiders buying shares. But for those who consider these important metrics, we encourage you to check out companies that do have those features. You can access a tailored list of companies which have demonstrated growth backed by significant insider holdings. Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
